Eye drug costs hit 'people's enjoyment of life'

A Guernsey resident believes "people's enjoyment in life" is being sacrificed for the financial cost of using a drug that can ...
MedPage Today on MSN

Could AI Transform AMD Care? Experts Say Yes

Lotery cautioned that AI's use in eye care has limitations. "AI models may underperform on underrepresented populations, AI ...

4DMT Announces Positive Long-Term Data from Phase 1/2 PRISM Clinical Trial in Wet AMD Supporting 4D-150’s Potential as a Backbone Therapy with Consistent and Durable Benefit ...

D-150 demonstrated consistent and durable benefit across all three patient cohorts as evidenced by maintenance of visual acuity, control of ...
Healio

‘One-and-done’ gene therapy could shift wet AMD treatment paradigm

A one-time subretinal injection of Sura-vec at both high- and low-dose concentrations allowed more than half of patients with neovascular AMD to be free of anti-VEGF injections through 1 year, ...
Healio

VIDEO: Extension studies shed light on wet AMD treatments

In this video from the American Academy of Ophthalmology meeting, Esther M. Bowie, MD, discusses results from the AVONELLE-X trial, the PULSAR trial and the Portal study in wet age-related macular ...
Ophthalmology Times

4DMT releases positive interim 1.5- to 3.5-year data from phase 1/2 PRISM trial

4D Molecular Therapeutics (4DMT) released positive interim 1.5- to 3.5-year data from the phase 1/2 PRISM clinical trial ...
Ophthalmology Times

Ocular Therapeutix reaches target enrollment of 555 patients in SOL-R trial

The SOL-R registrational trial (NCT06495918) of OTX-TKI (AXPAXLI) by Ocular Therapeutix has reached its randomization target of 555 patients.
Nasdaq

Clearside Biomedical’s Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting

ALPHARETTA, Ga., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the ...
WebMD

Treating Wet Age-Related Macular Degeneration (AMD) With Vabysmo

People with a condition called wet age-related macular degeneration (AMD) often receive eye injections. These eye injections can help to improve vision and also stop the damage that causes vision to ...